CD163(Antibody) Market - Global Outlook and Forecast 2023-2027

Report ID: 829873 | Published Date: Jan 2025 | No. of Page: 100 | Base Year: 2024 | Rating: 3.9 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Introduction to Research & Analysis Reports
    1.1 CD163(Antibody) Market Definition
    1.2 Market Segments
        1.2.1 Market by Type
        1.2.2 Market by Application
    1.3 Global CD163(Antibody) Market Overview
    1.4 Features & Benefits of This Report
    1.5 Methodology & Sources of Information
        1.5.1 Research Methodology
        1.5.2 Research Process
        1.5.3 Base Year
        1.5.4 Report Assumptions & Caveats
2 Global CD163(Antibody) Overall Market Size
    2.1 Global CD163(Antibody) Market Size: 2021 VS 2027
    2.2 Global CD163(Antibody) Market Size, Prospects & Forecasts: 2016-2027
    2.3 Key Market Trends, Opportunity, Drivers and Restraints
        2.3.1 Market Opportunities & Trends
        2.3.2 Market Drivers
        2.3.3 Market Restraints
3 Company Landscape
    3.1 Top CD163(Antibody) Players in Global Market
    3.2 Top Global CD163(Antibody) Companies Ranked by Revenue
    3.3 Global CD163(Antibody) Revenue by Companies
    3.4 Top 3 and Top 5 CD163(Antibody) Companies in Global Market, by Revenue in 2020
    3.5 Global Companies CD163(Antibody) Product Type
    3.6 Tier 1, Tier 2 and Tier 3 CD163(Antibody) Players in Global Market
        3.6.1 List of Global Tier 1 CD163(Antibody) Companies
        3.6.2 List of Global Tier 2 and Tier 3 CD163(Antibody) Companies
4 Market Sights by Product
    4.1 Overview
        4.1.1 By Type - Global CD163(Antibody) Market Size Markets, 2021 & 2027
        4.1.2 Above 95%
        4.1.3 Above 99%
        4.1.4 Others
    4.2 By Type - Global CD163(Antibody) Revenue & Forecasts
        4.2.1 By Type - Global CD163(Antibody) Revenue, 2016-2021
        4.2.2 By Type - Global CD163(Antibody) Revenue, 2022-2027
        4.2.3 By Type - Global CD163(Antibody) Revenue Market Share, 2016-2027
5 Sights by Application
    5.1 Overview
        5.1.1 By Application - Global CD163(Antibody) Market Size, 2021 & 2027
        5.1.2 Biopharmaceutical Companies
        5.1.3 Hospitals
        5.1.4 Bioscience Research Institutions
        5.1.5 Others
    5.2 By Application - Global CD163(Antibody) Revenue & Forecasts
        5.2.1 By Application - Global CD163(Antibody) Revenue, 2016-2021
        5.2.2 By Application - Global CD163(Antibody) Revenue, 2022-2027
        5.2.3 By Application - Global CD163(Antibody) Revenue Market Share, 2016-2027
6 Sights by Region
    6.1 By Region - Global CD163(Antibody) Market Size, 2021 & 2027
    6.2 By Region - Global CD163(Antibody) Revenue & Forecasts
        6.2.1 By Region - Global CD163(Antibody) Revenue, 2016-2021
        6.2.2 By Region - Global CD163(Antibody) Revenue, 2022-2027
        6.2.3 By Region - Global CD163(Antibody) Revenue Market Share, 2016-2027
    6.3 North America
        6.3.1 By Country - North America CD163(Antibody) Revenue, 2016-2027
        6.3.2 US CD163(Antibody) Market Size, 2016-2027
        6.3.3 Canada CD163(Antibody) Market Size, 2016-2027
        6.3.4 Mexico CD163(Antibody) Market Size, 2016-2027
    6.4 Europe
        6.4.1 By Country - Europe CD163(Antibody) Revenue, 2016-2027
        6.4.2 Germany CD163(Antibody) Market Size, 2016-2027
        6.4.3 France CD163(Antibody) Market Size, 2016-2027
        6.4.4 U.K. CD163(Antibody) Market Size, 2016-2027
        6.4.5 Italy CD163(Antibody) Market Size, 2016-2027
        6.4.6 Russia CD163(Antibody) Market Size, 2016-2027
        6.4.7 Nordic Countries CD163(Antibody) Market Size, 2016-2027
        6.4.8 Benelux CD163(Antibody) Market Size, 2016-2027
    6.5 Asia
        6.5.1 By Region - Asia CD163(Antibody) Revenue, 2016-2027
        6.5.2 China CD163(Antibody) Market Size, 2016-2027
        6.5.3 Japan CD163(Antibody) Market Size, 2016-2027
        6.5.4 South Korea CD163(Antibody) Market Size, 2016-2027
        6.5.5 Southeast Asia CD163(Antibody) Market Size, 2016-2027
        6.5.6 India CD163(Antibody) Market Size, 2016-2027
    6.6 South America
        6.6.1 By Country - South America CD163(Antibody) Revenue, 2016-2027
        6.6.2 Brazil CD163(Antibody) Market Size, 2016-2027
        6.6.3 Argentina CD163(Antibody) Market Size, 2016-2027
    6.7 Middle East & Africa
        6.7.1 By Country - Middle East & Africa CD163(Antibody) Revenue, 2016-2027
        6.7.2 Turkey CD163(Antibody) Market Size, 2016-2027
        6.7.3 Israel CD163(Antibody) Market Size, 2016-2027
        6.7.4 Saudi Arabia CD163(Antibody) Market Size, 2016-2027
        6.7.5 UAE CD163(Antibody) Market Size, 2016-2027
7 Players Profiles
    7.1 Thermo Fisher Scientific
        7.1.1 Thermo Fisher Scientific Corporate Summary
        7.1.2 Thermo Fisher Scientific Business Overview
        7.1.3 Thermo Fisher Scientific CD163(Antibody) Major Product Offerings
        7.1.4 Thermo Fisher Scientific CD163(Antibody) Revenue in Global (2016-2021)
        7.1.5 Thermo Fisher Scientific Key News
    7.2 R&D Systems
        7.2.1 R&D Systems Corporate Summary
        7.2.2 R&D Systems Business Overview
        7.2.3 R&D Systems CD163(Antibody) Major Product Offerings
        7.2.4 R&D Systems CD163(Antibody) Revenue in Global (2016-2021)
        7.2.5 R&D Systems Key News
    7.3 Lifespan Biosciences
        7.3.1 Lifespan Biosciences Corporate Summary
        7.3.2 Lifespan Biosciences Business Overview
        7.3.3 Lifespan Biosciences CD163(Antibody) Major Product Offerings
        7.3.4 Lifespan Biosciences CD163(Antibody) Revenue in Global (2016-2021)
        7.3.5 Lifespan Biosciences Key News
    7.4 Bio-Rad
        7.4.1 Bio-Rad Corporate Summary
        7.4.2 Bio-Rad Business Overview
        7.4.3 Bio-Rad CD163(Antibody) Major Product Offerings
        7.4.4 Bio-Rad CD163(Antibody) Revenue in Global (2016-2021)
        7.4.5 Bio-Rad Key News
    7.5 Abbexa Ltd
        7.5.1 Abbexa Ltd Corporate Summary
        7.5.2 Abbexa Ltd Business Overview
        7.5.3 Abbexa Ltd CD163(Antibody) Major Product Offerings
        7.5.4 Abbexa Ltd CD163(Antibody) Revenue in Global (2016-2021)
        7.5.5 Abbexa Ltd Key News
    7.6 Boster Bio
        7.6.1 Boster Bio Corporate Summary
        7.6.2 Boster Bio Business Overview
        7.6.3 Boster Bio CD163(Antibody) Major Product Offerings
        7.6.4 Boster Bio CD163(Antibody) Revenue in Global (2016-2021)
        7.6.5 Boster Bio Key News
    7.7 Atlas Antibodies
        7.7.1 Atlas Antibodies Corporate Summary
        7.7.2 Atlas Antibodies Business Overview
        7.7.3 Atlas Antibodies CD163(Antibody) Major Product Offerings
        7.4.4 Atlas Antibodies CD163(Antibody) Revenue in Global (2016-2021)
        7.7.5 Atlas Antibodies Key News
    7.8 Biobyt
        7.8.1 Biobyt Corporate Summary
        7.8.2 Biobyt Business Overview
        7.8.3 Biobyt CD163(Antibody) Major Product Offerings
        7.8.4 Biobyt CD163(Antibody) Revenue in Global (2016-2021)
        7.8.5 Biobyt Key News
    7.9 Novus Biologicals
        7.9.1 Novus Biologicals Corporate Summary
        7.9.2 Novus Biologicals Business Overview
        7.9.3 Novus Biologicals CD163(Antibody) Major Product Offerings
        7.9.4 Novus Biologicals CD163(Antibody) Revenue in Global (2016-2021)
        7.9.5 Novus Biologicals Key News
    7.10 Aviva Systems Biology
        7.10.1 Aviva Systems Biology Corporate Summary
        7.10.2 Aviva Systems Biology Business Overview
        7.10.3 Aviva Systems Biology CD163(Antibody) Major Product Offerings
        7.10.4 Aviva Systems Biology CD163(Antibody) Revenue in Global (2016-2021)
        7.10.5 Aviva Systems Biology Key News
    7.11 ProSci
        7.11.1 ProSci Corporate Summary
        7.11.2 ProSci Business Overview
        7.11.3 ProSci CD163(Antibody) Major Product Offerings
        7.11.4 ProSci CD163(Antibody) Revenue in Global (2016-2021)
        7.11.5 ProSci Key News
    7.12 BioLegend
        7.12.1 BioLegend Corporate Summary
        7.12.2 BioLegend Business Overview
        7.12.3 BioLegend CD163(Antibody) Major Product Offerings
        7.12.4 BioLegend CD163(Antibody) Revenue in Global (2016-2021)
        7.12.5 BioLegend Key News
8 Conclusion
9 Appendix
    9.1 Note
    9.2 Examples of Clients
    9.3 Disclaimer

List of Tables
    Table 1. CD163(Antibody) Market Opportunities & Trends in Global Market
    Table 2. CD163(Antibody) Market Drivers in Global Market
    Table 3. CD163(Antibody) Market Restraints in Global Market
    Table 4. Key Players of CD163(Antibody) in Global Market
    Table 5. Top CD163(Antibody) Players in Global Market, Ranking by Revenue (2019)
    Table 6. Global CD163(Antibody) Revenue by Companies, (US$, Mn), 2016-2021
    Table 7. Global CD163(Antibody) Revenue Share by Companies, 2016-2021
    Table 8. Global Companies CD163(Antibody) Product Type
    Table 9. List of Global Tier 1 CD163(Antibody) Companies, Revenue (US$, Mn) in 2020 and Market Share
    Table 10. List of Global Tier 2 and Tier 3 CD163(Antibody) Companies, Revenue (US$, Mn) in 2020 and Market Share
    Table 11. By Type – Global CD163(Antibody) Revenue, (US$, Mn), 2021 VS 2027
    Table 12. By Type - CD163(Antibody) Revenue in Global (US$, Mn), 2016-2021
    Table 13. By Type - CD163(Antibody) Revenue in Global (US$, Mn), 2022-2027
    Table 14. By Application – Global CD163(Antibody) Revenue, (US$, Mn), 2021 VS 2027
    Table 15. By Application - CD163(Antibody) Revenue in Global (US$, Mn), 2016-2021
    Table 16. By Application - CD163(Antibody) Revenue in Global (US$, Mn), 2022-2027
    Table 17. By Region – Global CD163(Antibody) Revenue, (US$, Mn), 2021 VS 2027
    Table 18. By Region - Global CD163(Antibody) Revenue (US$, Mn), 2016-2021
    Table 19. By Region - Global CD163(Antibody) Revenue (US$, Mn), 2022-2027
    Table 20. By Country - North America CD163(Antibody) Revenue, (US$, Mn), 2016-2021
    Table 21. By Country - North America CD163(Antibody) Revenue, (US$, Mn), 2022-2027
    Table 22. By Country - Europe CD163(Antibody) Revenue, (US$, Mn), 2016-2021
    Table 23. By Country - Europe CD163(Antibody) Revenue, (US$, Mn), 2022-2027
    Table 24. By Region - Asia CD163(Antibody) Revenue, (US$, Mn), 2016-2021
    Table 25. By Region - Asia CD163(Antibody) Revenue, (US$, Mn), 2022-2027
    Table 26. By Country - South America CD163(Antibody) Revenue, (US$, Mn), 2016-2021
    Table 27. By Country - South America CD163(Antibody) Revenue, (US$, Mn), 2022-2027
    Table 28. By Country - Middle East & Africa CD163(Antibody) Revenue, (US$, Mn), 2016-2021
    Table 29. By Country - Middle East & Africa CD163(Antibody) Revenue, (US$, Mn), 2022-2027
    Table 30. Thermo Fisher Scientific Corporate Summary
    Table 31. Thermo Fisher Scientific CD163(Antibody) Product Offerings
    Table 32. Thermo Fisher Scientific CD163(Antibody) Revenue (US$, Mn), (2016-2021)
    Table 33. R&D Systems Corporate Summary
    Table 34. R&D Systems CD163(Antibody) Product Offerings
    Table 35. R&D Systems CD163(Antibody) Revenue (US$, Mn), (2016-2021)
    Table 36. Lifespan Biosciences Corporate Summary
    Table 37. Lifespan Biosciences CD163(Antibody) Product Offerings
    Table 38. Lifespan Biosciences CD163(Antibody) Revenue (US$, Mn), (2016-2021)
    Table 39. Bio-Rad Corporate Summary
    Table 40. Bio-Rad CD163(Antibody) Product Offerings
    Table 41. Bio-Rad CD163(Antibody) Revenue (US$, Mn), (2016-2021)
    Table 42. Abbexa Ltd Corporate Summary
    Table 43. Abbexa Ltd CD163(Antibody) Product Offerings
    Table 44. Abbexa Ltd CD163(Antibody) Revenue (US$, Mn), (2016-2021)
    Table 45. Boster Bio Corporate Summary
    Table 46. Boster Bio CD163(Antibody) Product Offerings
    Table 47. Boster Bio CD163(Antibody) Revenue (US$, Mn), (2016-2021)
    Table 48. Atlas Antibodies Corporate Summary
    Table 49. Atlas Antibodies CD163(Antibody) Product Offerings
    Table 50. Atlas Antibodies CD163(Antibody) Revenue (US$, Mn), (2016-2021)
    Table 51. Biobyt Corporate Summary
    Table 52. Biobyt CD163(Antibody) Product Offerings
    Table 53. Biobyt CD163(Antibody) Revenue (US$, Mn), (2016-2021)
    Table 54. Novus Biologicals Corporate Summary
    Table 55. Novus Biologicals CD163(Antibody) Product Offerings
    Table 56. Novus Biologicals CD163(Antibody) Revenue (US$, Mn), (2016-2021)
    Table 57. Aviva Systems Biology Corporate Summary
    Table 58. Aviva Systems Biology CD163(Antibody) Product Offerings
    Table 59. Aviva Systems Biology CD163(Antibody) Revenue (US$, Mn), (2016-2021)
    Table 60. ProSci Corporate Summary
    Table 61. ProSci CD163(Antibody) Product Offerings
    Table 62. ProSci CD163(Antibody) Revenue (US$, Mn), (2016-2021)
    Table 63. BioLegend Corporate Summary
    Table 64. BioLegend CD163(Antibody) Product Offerings
    Table 65. BioLegend CD163(Antibody) Revenue (US$, Mn), (2016-2021)
List of Figures
    Figure 1. CD163(Antibody) Segment by Type
    Figure 2. CD163(Antibody) Segment by Application
    Figure 3. Global CD163(Antibody) Market Overview: 2020
    Figure 4. Key Caveats
    Figure 5. Global CD163(Antibody) Market Size: 2021 VS 2027 (US$, Mn)
    Figure 6. Global CD163(Antibody) Revenue, 2016-2027 (US$, Mn)
    Figure 7. The Top 3 and 5 Players Market Share by CD163(Antibody) Revenue in 2020
    Figure 8. By Type - Global CD163(Antibody) Revenue Market Share, 2016-2027
    Figure 9. By Application - Global CD163(Antibody) Revenue Market Share, 2016-2027
    Figure 10. By Region - Global CD163(Antibody) Revenue Market Share, 2016-2027
    Figure 11. By Country - North America CD163(Antibody) Revenue Market Share, 2016-2027
    Figure 12. US CD163(Antibody) Revenue, (US$, Mn), 2016-2027
    Figure 13. Canada CD163(Antibody) Revenue, (US$, Mn), 2016-2027
    Figure 14. Mexico CD163(Antibody) Revenue, (US$, Mn), 2016-2027
    Figure 15. By Country - Europe CD163(Antibody) Revenue Market Share, 2016-2027
    Figure 16. Germany CD163(Antibody) Revenue, (US$, Mn), 2016-2027
    Figure 17. France CD163(Antibody) Revenue, (US$, Mn), 2016-2027
    Figure 18. U.K. CD163(Antibody) Revenue, (US$, Mn), 2016-2027
    Figure 19. Italy CD163(Antibody) Revenue, (US$, Mn), 2016-2027
    Figure 20. Russia CD163(Antibody) Revenue, (US$, Mn), 2016-2027
    Figure 21. Nordic Countries CD163(Antibody) Revenue, (US$, Mn), 2016-2027
    Figure 22. Benelux CD163(Antibody) Revenue, (US$, Mn), 2016-2027
    Figure 23. By Region - Asia CD163(Antibody) Revenue Market Share, 2016-2027
    Figure 24. China CD163(Antibody) Revenue, (US$, Mn), 2016-2027
    Figure 25. Japan CD163(Antibody) Revenue, (US$, Mn), 2016-2027
    Figure 26. South Korea CD163(Antibody) Revenue, (US$, Mn), 2016-2027
    Figure 27. Southeast Asia CD163(Antibody) Revenue, (US$, Mn), 2016-2027
    Figure 28. India CD163(Antibody) Revenue, (US$, Mn), 2016-2027
    Figure 29. By Country - South America CD163(Antibody) Revenue Market Share, 2016-2027
    Figure 30. Brazil CD163(Antibody) Revenue, (US$, Mn), 2016-2027
    Figure 31. Argentina CD163(Antibody) Revenue, (US$, Mn), 2016-2027
    Figure 32. By Country - Middle East & Africa CD163(Antibody) Revenue Market Share, 2016-2027
    Figure 33. Turkey CD163(Antibody) Revenue, (US$, Mn), 2016-2027
    Figure 34. Israel CD163(Antibody) Revenue, (US$, Mn), 2016-2027
    Figure 35. Saudi Arabia CD163(Antibody) Revenue, (US$, Mn), 2016-2027
    Figure 36. UAE CD163(Antibody) Revenue, (US$, Mn), 2016-2027
    Figure 37. Thermo Fisher Scientific CD163(Antibody) Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
    Figure 38. R&D Systems CD163(Antibody) Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
    Figure 39. Lifespan Biosciences CD163(Antibody) Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
    Figure 40. Bio-Rad CD163(Antibody) Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
    Figure 41. Abbexa Ltd CD163(Antibody) Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
    Figure 42. Boster Bio CD163(Antibody) Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
    Figure 43. Atlas Antibodies CD163(Antibody) Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
    Figure 44. Biobyt CD163(Antibody) Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
    Figure 45. Novus Biologicals CD163(Antibody) Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
    Figure 46. Aviva Systems Biology CD163(Antibody) Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
    Figure 47. ProSci CD163(Antibody) Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Please ask for Sample Report to see list of companies covered. Request Sample Report
Frequently Asked Questions
CD163 Market In Global report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
CD163 Market In Global report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
CD163 Market In Global report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

ENG Market In Global

This report contains market size and forecasts of ENG(Endoglin Precursor) in Global, including th ... Read More